Pupillometer Market

Global Pupillometer Market Size (2023 to 2028)

The size of the global pupillometer market is anticipated to be valued at USD 626.7 million by 2028 from USD 444.3 million in 2023, growing at a CAGR of 7.12% from 2023 to 2028.

Global Pupillometer Market Share Insights:

• Based on modality, the table-top segment held the leading share of the global market in 2022.
• Based on type, the video segment led the market in 2022.
• Based on end-use, the hospital segment accounted for the largest share of the global market in 2022.
• Based on application, the ophthalmology segment was the biggest segment in the worldwide market in 2022.
• Based on region, North America dominated the market in 2022.

Impact of COVID-19 on the pupillometer market:

The COVID-19 pandemic had both positive and negative effects on the global pupillometer market. On the one hand, there was a rise in demand for pupillometers in certain healthcare settings such as intensive care units and emergency rooms, where pupillometry is important for figuring out what's wrong with the brain. The COVID-19 pandemic showed how important it is to find and track neurological problems early on. As a result, pupillometers are being used more often in these settings. The need for diagnostic pupillometers was also driven by the growing knowledge of how COVID-19 could affect the brain.

During the COVID-19 pandemic, on the other hand, the world's healthcare system had to deal with problems like overcrowded hospitals, broken supply chains, and limits on non-essential medical treatments. These things affected the production, sale, and use of pupillometers in some areas, temporarily slowing the market’s growth. In the time after the COVID-19 pandemic, however, more people will know about the long-term effects of COVID-19 on the nervous system and the need for more thorough patient monitoring, which is likely to drive the market for pupillometers.

MARKET DRIVERS:

The growing patient population suffering from neurological diseases is one of the major factors propelling the pupillometer market growth. The rising prevalence of neurological conditions such as traumatic brain injuries, strokes, and neurodegenerative diseases has resulted in an increase in the need for pupillometers. various instruments are critical for assessing and monitoring pupillary responses, which can provide vital insights into neurological function and aid in diagnosing, treating, and managing various diseases. According to the World Health Organization (WHO), neurological disorders affect millions of people worldwide, with conditions such as epilepsy, Alzheimer's disease, and Parkinson's disease being highly prevalent.

Technological advancements further promote the market growth. As technology has improved, pupilometers have become more advanced and easier to use. They can now take high-resolution photos, analyse data in real time, and measure pupillary responses automatically. When artificial intelligence (AI) and machine learning methods are added to pupillometry, they make it even more accurate and efficient. Also, research and development efforts are given much attention in pupillometry.  These technological advances make it easier for pupillometers to be used in a wide range of healthcare settings. Pupilometers' enhanced capabilities have broadened their applications across a variety of medical specialities, fuelling market growth. The developments in pupillometry technology are highlighted in research studies and publications in top medical journals, demonstrating modern pupillometers' greater accuracy, dependability, and versatility of modern pupillometers. These technological breakthroughs have boosted diagnostic capabilities and patient outcomes.

Early detection and intervention for different health diseases, especially neurological illnesses, are becoming increasingly important. Pupillometry is a non-invasive and objective way of evaluating pupillary reflexes that can help in the early detection of neurological disorders. This motivates using pupillometers in hospitals, clinics, and research facilities.

Spending on healthcare worldwide is slowly increasing because of a growing population, an ageing population, and the need for more improved medical technologies. The market for pupillometers is helped by the fact that much money goes to healthcare infrastructure and medical products. Governments and healthcare organisations are buying modern testing tools like pupillometers to improve patient care and health outcomes.

MARKET RESTRAINTS:

High costs associated with pupillometers primarily hampers the market growth. Pupillometers can be expensive, especially those with extensive features and technologies. The high cost of these devices can make them unaffordable and inaccessible, particularly in resource-constrained healthcare settings or regions with restricted healthcare budgets. The need for more awareness and expertise regarding pupillometry techniques and their clinical uses among healthcare providers can stymie pupillometer adoption. While pupillometers provide an objective and non-invasive examination of pupillary responses, other diagnostic instruments and methods, such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and electroencephalography (EEG), are available for evaluating neurological problems. Depending on the individual clinical scenario and available resources, healthcare providers may opt for alternate diagnostic techniques, limiting the necessity for pupillometers. Pupillometry procedure coverage and reimbursement rules differ between healthcare systems and insurance carriers. Adoption and use of pupillometers can be hampered by a lack of proper reimbursement, particularly in areas where healthcare expenditures are high.

REPORT COVERAGE: 

This research report on global pupillometer market has been segmented and sub-segmented based on the following categories.

Global Pupillometer Market – By Mobility:

• Table-top
• Hand-held

Based on the modality, the table-top segment is expected to account for the leading share of the global market in the coming years. High precision and advanced features provided by table-top pupillometers is one of the major factors propelling the growth of the table-top segment in the worldwide. The growing adoption in research institutions for studying pupillary responses in various neurological disorders and drug testing and rising incidence of eye-related conditions and neurological disorders further boost the growth rate of the table-top segment.

The hand- held segment had a substantial share of the worldwide market in 2022 and is expected to witness the fastest CAGR in the coming years. The growing demand for portable and compact medical devices that can be used in diverse clinical scenarios, rising emphasis on early detection and assessment of neurological conditions and technological advancements that enable hand-held pupillometers to offer accurate and reliable results similar to table-top models contribute to the growth of the hand-held segment.

Global Pupillometer Market – By Type:

• Video
• Digital

Based on type, the video segment had the largest share of the global market in 2022 and is expected to grow at a healthy CAGR in the coming years owing to the rising demand for non-invasive and automated pupillometry techniques for quick and accurate assessment of neurological conditions and traumatic brain injuries. The rapid adoption in intensive care units (ICUs) and emergency departments, where timely pupillary evaluations assist in diagnosing and managing patients with neurological disorders and advancements in video pupillometer technology further propel the growth of the video segment in the global market.

The digital segment is anticipated to account for a substantial share of the worldwide market in the coming years. The growing prevalence of eye-related disorders and vision abnormalities, rising awareness among healthcare professionals about the significance of pupillary assessments as a diagnostic and prognostic tool and the availability of cost-effective and handheld digital pupillometers majorly drive the growth of the digital segment.

Global Pupillometer Market – By Application:

• Ophthalmology
• Neurology
• Oncology
• Others

Based on application, the ophthalmology segment is estimated to hold the major share of the global market during the forecast period. The growing prevalence of eye-related disorders and vision impairments, necessitating accurate and objective pupillary evaluations for early detection and treatment and advancements in pupillometer technology that offer high-resolution imaging and precise measurements for comprehensive ophthalmological assessments propel the growth of the ophthalmology segment in the global market.

Global Pupillometer Market – By End-use:

• Hospitals
• Eye Clinics
• Others

Based on end-use, the hospitals segment dominated the pupillometer market in 2022 and the domination of the segment is likely to continue throughout the forecast period. The growing patient admissions in hospitals resulted in the increased demand for pupillometry equipment for comprehensive patient evaluation and is one of the key drivers propelling the growth of the hospital segment. The rising awareness among healthcare providers about the significance of pupillary assessments in improving clinical outcomes and treatment decisions further drive the growth of the hospital segment in the global market.

Global Pupillometer Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

North America held the major share of the worldwide market in 2022 and the lead of the North American region in the global market is likely to continue throughout the forecast period. The growing patient population suffering from traumatic brain injuries and neurological disorders in the United States and Canada drives the growth of the pupillometer market in North America. As per the statistics published by the Brain Injury Association of America, an estimated more than 2.5 million traumatic brain injury-related emergency department visits in the United States each year. The rising awareness about early detection and management of eye diseases and favorable reimbursement policies and government initiatives supporting the use of advanced medical devices, including pupillometers further fuel the growth rate of the North American market.

Europe is a promising regional market for pupillometers and is anticipated to account for a substantial share of the global market during the forecast period. The growing incidence of cataracts, glaucoma, and other eye disorders among the elderly population in Europe, advancements in digital healthcare technologies and telemedicine, increasing investments in research and development activities for innovative medical devices, including pupillometers drive the growth of the European market. An estimated 30 million people in Europe have age-related macular degeneration says the European Eye Epidemiology Consortium.

APAC is the most lucrative regional market for pupillometers and is estimated to witness the fastest CAGR during the forecast period. High incidence of diabetes in countries like India and China that results in the higher demand for pupillometry for diabetic retinopathy screening, growing access to healthcare services and increasing disposable income propel the APAC market growth. An increasing number of initiatives from the governments of APAC countries to promote healthcare infrastructure development and investment in medical technologies contributes to the APAC market growth.

KEY MARKET PLAYERS:

NeurOptics, Inc., Natus Medical Incorporated, Neuro Kinetics, Inc., Essilor Instruments USA, AMTech International Srl, Konan Medical USA, Inc., US Ophthalmic LLC, XCSOURCE LLC, InnoviMedical and Aidata Medical are some of the notable companies in the global pupillometer market.

RECENT HAPPENINGS IN THE MARKET:

• In September 2022, according to a new peer-reviewed study published in BMC Neurology, even one occurrence of an abnormal Neurological Pupil index (NPi) differential, measured by NeurOptics’ NPi Pupillometer, can be an early indicator of neurological injury. Automated pupillometry has become a crucial technology for measuring the Neurological Pupil Index (NPi), which quantitatively expresses pupil size and response.
• In January 2023, according to a recent clinical study published in The Journal of the American College of Emergency Physicians, clinical intoxication does not affect NeurOptics' Automated Pupillometry and the Neurological Pupil Index (NPi), which means they can be used to quickly screen patients in the emergency room for brain or neurological injuries.